Kelsey Lang provides strategic advice to clients on a range of complex coverage, access, and reimbursement topics.
She leverages her experience working with providers, plans, and pharmaceutical manufacturers to help clients navigate the evolving policy landscape, with a particular focus on Medicare and other government programs.
Before joining Avalere, Kelsey was head of Policy at Novo Nordisk, where she and her team led work to remove policy barriers to accessing anti-obesity medications, shape the 340B policy landscape, and advise the company on the Inflation Reduction Act and other drug pricing initiatives. Prior to that, she was a director of Federal Policy and Government Affairs at Bristol Myers Squibb, where she was responsible for the development of policy positions on a range of topics and led engagements with trade associations, patient advocates, and policymakers. She was a deputy vice president at PhRMA and spearheaded the association’s work on Medicare Part B and the Center for Medicare and Medicaid Innovation, and also held policy roles at the American Academy of Ophthalmology and URAC.
Kelsey has a MPP in health policy from Georgetown University and a BA in Women’s Studies from The George Washington University.